Home / Companies / Actinium Pharmaceuticals Inc / Trends
Actinium Pharmaceuticals Inc H-1B trends
Quarterly LCA aggregate trend points for Actinium Pharmaceuticals Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Actinium Pharmaceuticals Inc span 2019 Q2 to 2022 Q4, peaking at 3 filings in 2022 Q4.
The most recent reported period (2022 Q4) shows 3 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2019 Q2 | 1 | 1 | 1 | $58,240 | $56,160 | 1 | 100.0% |
| 2022 Q4 | 3 | 1 | 3 | $125,068 | $115,468 | 3 | 100.0% |
Frequently asked questions
- How have H-1B filings for Actinium Pharmaceuticals Inc changed over time?
- H-1B LCA filings for Actinium Pharmaceuticals Inc span 2019 Q2 to 2022 Q4, peaking at 3 filings in 2022 Q4. The most recent reported period (2022 Q4) shows 3 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=actinium+pharmaceuticals+inc&metric=lca_countJSON